XenoTherapeutics Executives Spearhead Initial Hurricane Michael Relief Efforts in Panama City, Florida

October 23, 2018

XenoTherapeutics, a life science company developing the first non-human organ transplant solution currently under investigational review by the FDA, announced that company co-founders Paul Holzer, CEO and Jon Adkins, COO, along with a team of former military and first responder volunteers, traveled some 1500 miles from their homes in New Hampshire to deliver emergency aid in the immediate aftermath of Hurricane Michael.